| The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients L Premkumar, B Segovia-Chumbez, R Jadi, DR Martinez, R Raut, ... Science immunology 5 (48), eabc8413, 2020 | 874 | 2020 |
| An envelope domain III-based chimeric antigen produced in Pichia pastoris elicits neutralizing antibodies against all four dengue virus serotypes B Etemad, G Batra, R Raut, S Dahiya, S Khanam, S Swaminathan, ... Am J Trop Med Hyg 79 (3), 353-363, 2008 | 122 | 2008 |
| Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes R Sood, R Raut, P Tyagi, PK Pareek, TK Barman, S Singhal, ... PLoS neglected tropical diseases 9 (12), e0004255, 2015 | 105 | 2015 |
| Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies R Raut, KS Corbett, RN Tennekoon, S Premawansa, A Wijewickrama, ... Proceedings of the National Academy of Sciences 116 (1), 227-232, 2019 | 79 | 2019 |
| A tetravalent virus-like particle vaccine designed to display domain III of dengue envelope proteins induces multi-serotype neutralizing antibodies in mice and macaques which … V Ramasamy, U Arora, R Shukla, A Poddar, RK Shanmugam, LJ White, ... PLoS neglected tropical diseases 12 (1), e0006191, 2018 | 77 | 2018 |
| Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies S Mani, L Tripathi, R Raut, P Tyagi, U Arora, T Barman, R Sood, A Galav, ... PLoS one 8 (5), e64595, 2013 | 72 | 2013 |
| A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture R Raut, H Beesetti, P Tyagi, I Khanna, SK Jain, VU Jeankumar, ... Virology journal 12, 1-7, 2015 | 58 | 2015 |
| Severe dengue epidemic, Sri Lanka, 2017 HA Tissera, BDW Jayamanne, R Raut, SMD Janaki, Y Tozan, ... Emerging infectious diseases 26 (4), 682, 2020 | 54 | 2020 |
| Pichia pastoris-expressed dengue virus type 2 envelope domain III elicits virus-neutralizing antibodies G Batra, R Raut, S Dahiya, N Kamran, S Swaminathan, N Khanna Journal of virological methods 167 (1), 10-16, 2010 | 49 | 2010 |
| Sex disparities and neutralizing-antibody durability to SARS-CoV-2 infection in convalescent individuals AJ Markmann, N Giallourou, DR Bhowmik, YJ Hou, A Lerner, DR Martinez, ... Msphere 6 (4), 10.1128/msphere. 00275-21, 2021 | 46 | 2021 |
| Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies L Tripathi, S Mani, R Raut, A Poddar, P Tyagi, U Arora, A De Silva, ... Frontiers in microbiology 6, 1005, 2015 | 38 | 2015 |
| Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris N Kaushik, D Rohila, U Arora, R Raut, U Lamminmäki, N Khanna, G Batra BMC biotechnology 16, 1-9, 2016 | 33 | 2016 |
| The RBD of the Spike Protein of SARS-Group Coronaviruses is a highly specific target of SARS-CoV-2 antibodies but not other pathogenic human and animal coronavirus antibodies L Premkumar, B Segovia-Chumbez, R Jadi, DR Martinez, R Raut, ... MedRxiv, 2020.05. 06.20093377, 2020 | 27 | 2020 |
| Convalescent plasma therapy in four critically ill pediatric patients with coronavirus disease 2019: a case series SP Schwartz, P Thompson, M Smith, DM Lercher, CA Rimland, L Bartelt, ... Critical Care Explorations 2 (10), e0237, 2020 | 16 | 2020 |
| Dengue-specific subviral nanoparticles: design, creation and characterization N Khetarpal, A Poddar, SK Nemani, N Dhar, A Patil, P Negi, A Perween, ... Journal of nanobiotechnology 11, 1-8, 2013 | 16 | 2013 |
| The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients, Sci. Immunol. 5 (2020) L Premkumar, B Segovia-Chumbez, R Jadi, DR Martinez, R Raut, ... | 13 | |
| Erratum for Markmann et al.,“Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals” AJ Markmann, N Giallourou, DR Bhowmik, YJ Hou, A Lerner, DR Martinez, ... Msphere 6 (5), 10.1128/msphere. 00736-21, 2021 | 4 | 2021 |
| Anti dengue activity of PK Bhatnagar, CK Katiyar, N Khanna, DJ Upadhyay, S Swaminathan, ... Cissampelos pareira, 2011 | 4 | 2011 |
| Anti dengue activity of Cissampelos pareira extracts PK Bhatnagar, CK Katiyar, N Khanna, DJ Upadhyay, S Swaminathan, ... US Patent 9,707,261, 2017 | 2 | 2017 |
| Implementation Of Anonymous Vehicle Reporting And Communication System For Wrongly Parked Vehicle. HN Renushe, BR Patil, AAP Nikam, AR Dhang, RR Raut, VR Kadam, ... Journal of Advanced Zoology 45 (1), 2024 | | 2024 |
